Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

4.70
-0.1000-2.08%
Post-market: 4.820.1236+2.63%19:14 EDT
Volume:118.27K
Turnover:561.48K
Market Cap:8.52M
PE:-0.20
High:4.86
Open:4.62
Low:4.62
Close:4.80
Loading ...
Feb 25, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 21, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 14, 2021

Major Issues Report

8-K - Current report
Sep 14, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 16, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 13, 2021

Major Issues Report

8-K - Current report
Jul 12, 2021

Major Issues Report

8-K - Current report
Jul 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 08, 2021

Major Issues Report

8-K - Current report
Jun 24, 2021

Major Issues Report

8-K - Current report
Jun 04, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]